Drug
Digoxin clinical trials
Also written Lanoxin.
How each study uses Digoxin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Digoxin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 16 Nov 1954 · LANOXIN PEDIATRIC · NDA 009330 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
86 studies that test it; most in 2020 (8)
| Year | Studies |
|---|---|
| 2006 | 5 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 7 |
| 2015 | 2 |
| 2016 | 6 |
| 2017 | 5 |
| 2019 | 4 |
| 2020 | 8 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 7 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 43 · Other 44
Boehringer Ingelheim (9) · Yale University (3) · AstraZeneca (3) · University of Monastir (2) · Merck Sharp & Dohme LLC (2) · GlaxoSmithKline (2) · Assistance Publique - Hôpitaux de Paris (2) · Beijing QL Biopharmaceutical Co.,Ltd (1)
Often tested with
Tested in the same studies.
Rosuvastatin (15) · Metformin (10) · Midazolam (7) · Furosemide (7) · Warfarin (4) · Verapamil (4) · Simvastatin (3) · Bisoprolol (3)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 4
Studies that test Digoxin.
- Dec 2026Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese ParticipantsPhase 1 · Beijing QL Biopharmaceutical Co.,Ltd
- Dec 2026Phase IB Metformin, Digoxin, Simvastatin in Solid TumorsPhase 1 · Danae Hamouda, MD
- Jan 2027Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal CancerPhase 1/2 · Fudan University
- Feb 2027Digoxin Medulloblastoma StudyPhase 2 · H. Lee Moffitt Cancer Center and Research Institute
Studies
Open first, then newest update. How each study uses Digoxin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 87
- Digoxin Medulloblastoma StudyRecruitingPhase 2H. Lee Moffitt Cancer Center and Research InstituteNCT06701812Written as Digoxin
- Digoxin After Acute Heart Failure (DIG-DICA)RecruitingPhase 4Hospital General de Agudos "Dr. Cosme Argerich"NCT07321509Written as Digoxin
- Digoxin In NASH (CODIN)RecruitingPhase 2Yale UniversityNCT06588699Written as Digoxin
- Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal CancerNot yet recruitingPhase 1/2Fudan UniversityNCT07025850Written as Digoxin
- Digoxin and Senolysis in Heart Failure and Diabetes MellitusNot yet recruitingPhase 2University of LeedsNCT06240403Written as Digoxin 0.125 MG
- Digoxin Short Term Treatment Assessment Randomized Trial in AHFCompletedPhase 3University of MonastirNCT02544815Written as Digoxin
- Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese ParticipantsActive, not recruitingPhase 1Beijing QL Biopharmaceutical Co.,LtdNCT07550816Written as ZT002 injection, rosuvastatin, digoxin
- FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic CancerTerminatedPhase 2University of NebraskaNCT04141995Written as Digoxin
- A Research Study of the Effect of Etavopivat on Other Drugs in Healthy ParticipantsCompletedPhase 1Novo Nordisk A/SNCT06813924Written as Digoxin
- Digoxin In Treatment of Alcohol Associated HepatitisTerminatedPhase 2Yale UniversityNCT05014087Written as Intravenous digoxin
- PK/PD of Digoxin in Infants With SVHDCompletedPhase 1/2Duke UniversityNCT06613477Written as PK/PD Model Based Dosing of Digoxin in Infants with Single Ventricle Heart Disease
- Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)CompletedPhase 2Massachusetts General HospitalNCT07047209Written as Digoxin
- A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and DigoxinCompletedPhase 1Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT07118215Written as Digoxin
- A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT06186622Written as Digoxin
- Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the NetherlandsCompletedPhase 4University Medical Center GroningenNCT03783429Written as Digoxin
- A Study of Calderasib (MK-1084) With Midazolam and Digoxin in Healthy Participants (MK-1084-009)CompletedPhase 1Merck Sharp & Dohme LLCNCT06575933Written as Digoxin
- Rate Control in Patients With Atrial FibrillationCompletedNot applicableNational Taiwan University HospitalNCT04513509Written as Atenolol, Bisoprolol, Metoprolol, Nebivolol, Propranolol, Diltiazem, Verapamil, digoxin
- A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver CirrhosisCompletedNot applicableBoehringer IngelheimNCT05741372Written as Digoxin
- Effect of Estrogen Treatment on Drug Metabolism and TransportCompletedPhase 4University of WashingtonNCT05469204Written as Digoxin Oral Tablet
- Drug-Drug Interaction Study of Evobrutinib and Transporter SubstratesCompletedPhase 1Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT05064488Written as Digoxin (0.25mg)
See all 87 studies that test Digoxin →
Given beside what is tested · 79 — Digoxin is usual care or a partner of the new treatment
- A Phase I Study of the Interaction of D-2570 With Other Drugs in Healthy AdultsNot yet recruitingPhase 1InventisBio Co., LtdNCT07875842Written as Digoxin
- Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or ObesityRecruitingPhase 1The United Bio-Technology (Hengqin) Co., Ltd.NCT07785934Written as Digoxin
- Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and DigoxinNot yet recruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07502001Written as Digoxin
- Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)RecruitingPhase 3Advenchen Laboratories, LLCNCT03016819Written as Digoxin (0.25mg)
- A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.Not yet recruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06601517Written as Digoxin
- Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 InjectionCompletedPhase 1Gan & Lee Pharmaceuticals.NCT07128888Written as GZR18 injection,digoxin tablets, rosuvastatin calcium tablets and warfarin sodium tablets
- A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.CompletedPhase 1AbbVieNCT07567781Written as Digoxin
- A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight SubjectsCompletedPhase 1Shandong Suncadia Medicine Co., Ltd.NCT07269756Written as Digoxin Tablets
- Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin HydrochlorideCompletedPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT04621669Written as digoxin
- Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and DigoxinCompletedPhase 1EpiEndo PharmaceuticalsNCT06118684Written as Digoxin (Part B)
- Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and DigoxinCompletedPhase 1Boehringer IngelheimNCT02783040Written as Digoxin
- A Phase 1 Study of PROT-001.CompletedPhase 1Protego Biopharma Pty LtdNCT06981299Written as Digoxin 0.25 mg
- Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and DigoxinActive, not recruitingPhase 1Guangdong Raynovent Biotech Co., LtdNCT07362030Written as Digoxin Tablets
- A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the BodyCompletedPhase 1Boehringer IngelheimNCT07215260Written as Digoxin
- A Study of Imlunestrant (LY3484356) in Female Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT05444556Written as Digoxin
- Pemvidutide (ALT-801) DDI Study in Healthy VolunteersCompletedPhase 1Altimmune, Inc.NCT04972396Written as Digoxin
- Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy SubjectsCompletedPhase 1Fujian Shengdi Pharmaceutical Co., Ltd.NCT06723691Written as Digoxin
- A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or DigoxinCompletedPhase 1Hangzhou Sciwind Biosciences Co., Ltd.NCT06335134Written as Digoxin
- The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of DigoxinCompletedPhase 1Bial - Portela C S.A.NCT02172742Written as Digoxin
- Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy ParticipantsCompletedPhase 1AmgenNCT05598281Written as Digoxin
Showing 20 of 79.
As the comparator · 5 — what is tested is compared with Digoxin
- New Horizons for the Treatment of Cardiomyopathy in ChildrenTerminatedNot applicableDamascus UniversityNCT04893629Written as Digoxin+furosemide+captopril
- IvaBRAdine blocK of Funny Current for Heart Rate Control in permanEnt Atrial Fibrillation. (BRAKE-AF Study).CompletedPhase 3Adolfo FontenlaNCT03718273Written as Digoxin
- Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection FractionStatus unknownPhase 3Chun-Yao HuangNCT04308031Written as Digoxin 0.25 mg
- Digoxin Withdrawal in Stable Heart FailureCompletedNot applicableThe AlfredNCT01398371Written as Digoxin
- Spanish Atrial Fibrillation And Resynchronization StudyCompletedPhase 4Hospital Clinic of BarcelonaNCT01181414Written as Beta blocker/digoxine/amiodarone
What changed recently
From the registry's own updates since Oct 15, 2026.
Results posted1
- FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic CancerOct 21, 2026NCT04141995
Codes
What other systems call Digoxin · ClinicalTrials.gg INT007353
- MeSH (NLM) D004077DigoxinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 73K4184T59DIGOXINConfirmed FDA, NLM, Wikidata
- RxNorm 3407Confirmed FDA, Wikidata
- Wikidata Q422222digoxinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C28990DigoxinOne source FDA
- DrugBank DB00390One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D004077 | Digoxin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 73K4184T59 | DIGOXIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 3407 | — | Confirmed FDA, Wikidata |
| Wikidata | Q422222 | digoxin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C28990 | Digoxin | One source FDA |
| DrugBank | DB00390 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.